COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,395 Articles (22,816 medRxiv, 8,579 bioRxiv)

Most recent first Previous |  Page 141: Articles 1401-1410  | Next

Impact of the Covid-19 pandemic on elective and trauma orthopaedic surgery in a tertiary referral hospital in Kenya: A retrospective cross-sectional study
Baraza, N., Odari, I., Lomole, E. M., Karanja, S., Atinga, M.
10.1101/2024.12.10.24318827 — Posted: 2024-12-11
Return-to-work for People Living with Long COVID: A Scoping Review of Interventions and Recommendations
Nagra, G., Ezeugwu, V. E., Bostick, G. P., Branton, E., Dennett, L., Drake, K., Durand-Moreau, Q., Guptill, C., Hall, M., Ho, C., Hung, P., Khan, A., Lam, G. Y., Nowrouzi-Kia, B., Gross, D. P.
10.1101/2024.12.10.24318765 — Posted: 2024-12-11
COVID-19 vaccination and short-term mortality risk: a nationwide self-controlled case series study in The Netherlands
Slurink, I. A., de Boer, A., Bonten, M. M., Sturkenboom, M. C., Bruijning-Verhagen, P. C.
10.1101/2024.12.11.24318790 — Posted: 2024-12-11
Gut Microbiome Signatures During Acute Infection Predict Long COVID
Comba, I. Y., Mars, R. T., Yang, L., Dumais, M., Chen, J. Y., Van Gorp, T. M., Harrington, J. J., Sinnwell, J. P., Johnson, S., Holland, L. R., Khan, A. K., Lim, E., Aakre, C., Athreya, A., Gerber, G. K., O'Horo, J. C., Lazaridis, K., Kashyap, P. C.
10.1101/2024.12.10.626852 — Posted: 2024-12-11
Lipid specificity of action of SARS-CoV-2 fusion peptide fragments on model membranes
Shekunov, E. V., Volynsky, P. E., Efimova, S. S., Aliper, E. T., Efremov, R. G., Ostroumova, O. S.
10.1101/2024.12.11.627892 — Posted: 2024-12-11
Alignment Free Viral Sequence Classification
van Zyl, D. J., Dunaiski, M., Tegally, H., Baxter, C., The INFORM Africa research study group, , de Oliveira, T., Xavier, J. S.
10.1101/2024.12.10.627186 — Posted: 2024-12-11
Covid-19 vaccination decisions and impacts of vaccine mandates: A cross sectional survey of healthcare workers in British Columbia, Canada.
Chaufan, C., Hemsing, N., Moncrieffe, R.
10.1101/2024.12.09.24318733 — Posted: 2024-12-10
Neutralizing antibody titers predict protection from virus transmission in a cohort of household members with documented exposure to SARS-CoV-2
Maass, H., Hinrichs, I., Pavletic, M., Harries, M., Prinke, T., Bdeir, N., Egelkamp, R., Lange, B., Bartsch, Y., Lerga, M., Cicin-Sain, L.
10.1101/2024.12.10.24318774 — Posted: 2024-12-10
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Results of a pilot study in the SIREN cohort
Foulkes, S., Munro, K., Sparkes, D., Broad, J., Platt, N., Howells, A., Akinbami, O., Khawam, J., Joshi, P., Russell, S., Norman, C., Price, L., Corrigan, D., Cole, M., Timeyin, J., Forster, L., Slater, K., Watson, C. H., Andrews, N., Charlett, A., Atti, A., Islam, J., Brown, C. S., Turner, J., Hopkins, S., Hall, V., SIREN Study Group
10.1101/2024.12.09.24318698 — Posted: 2024-12-10
Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike Protein
Feng, Z., Huang, J., Baboo, S., Diedrich, J. K., Bangaru, S., Paulson, J. C., Yates, J. R., Yuan, M., Wilson, I. A., Ward, A. B.
10.1101/2024.12.10.627775 — Posted: 2024-12-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).